http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2392858-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10efc646a4dd605c2f09c493718f5b81 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145 |
| filingDate | 2009-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14ca3374b702bcde0463f1e78241ab1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d9898b4c5022f4ecaf8c890b68326e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f3cf84c5a838e5aae4b47d8f1874fe2 |
| publicationDate | 2010-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2392858-C1 |
| titleOfInvention | Method of severity assessment for hemorrhagic fever with renal syndrome |
| abstract | FIELD: medicine. ^ SUBSTANCE: invention refers to medicine, particularly to infectious disease area. Severity assessment for hemorrhagic fever with renal syndrome involves blood examination, particularly content of circulating endothelial cell (CEC) content. Medium form of hemorrhagic fever with renal syndrome is determined by CEC level increase to 6.4-10.0ù104/l. Severe form of disease free of complications is determined by CEC level increase to 10.7-14.6ù104/l. Severe form of hemorrhagic fever with renal syndrome and complications is determined by CEC level increase to 14.9-21.0ù104/l in the background of express clinical presentation. ^ EFFECT: objective and reliable determination of hemorrhagic fever severity, reduced analysis time. ^ 1 tbl, 3 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2706603-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2790962-C1 |
| priorityDate | 2009-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.